Implants News and Research

RSS

US Spine introduces Phantom Plus Interbody Fusion System

US Spine® is pleased to announce the launch of the Phantom Plus™ Interbody Fusion System. Phantom Plus provides spine surgeons with next generation instrumentation and implants that offer a compliment to US Spine’s posterior fixation systems. Features include tapered leading edges for easy insertion, a higher degree of doming to more closely match endplate anatomy, anti-migration teeth, and advanced instrumentation for multiple insertion techniques.

7 Oct 2009

HRT may increase urinary incontinence in postmenopausal women

Grappling with the risks and benefits of hormone replacement therapy (HRT) is nothing new for postmenopausal women. Researchers have now added more fuel to the fire, with evidence that HRT could play a role in incontinence.

7 Oct 2009

Uroplasty's Urgent PC and Macroplastique presented at the International Continence Society Meeting

Uroplasty, Inc., a medical device company developing, manufacturing and marketing innovative proprietary products for the treatment of voiding dysfunctions, today highlighted presentations, workshops and posters focused on its products at the 39th Annual Meeting of the International Continence Society Meeting (ICS), September 29 - October 3 in San Francisco.

7 Oct 2009

USPTO grants Micardia's patent concerning reshaping the anatomy of the heart

MiCardia® today announced that The United States Patent Office granted patent number US7,594,887 B2, "Shape Memory Devices and Methods for Reshaping Heart Anatomy," on September 29th, 2009.

3 Oct 2009

Five-year follow-up study reveals the efficacy of OsseoSpeed implant

The five-year follow-up study was made by Dr. Steveling and co-workers at the Department of Oral and Maxillofacial Surgery at the Heidelberg University in Germany. The conclusion is that the OsseoSpeed implant shows very good results also in compromised sites when using an early loading protocol.

3 Oct 2009

RSB Spine signs master distribution agreement with Paradigm BioDevices

RSB Spine, LLC, today announced that it has signed an exclusive master distribution agreement with Paradigm BioDevices, Inc. for the U.S. market. Paradigm BioDevices was instrumental in developing the Stand Alone 360 market for ZERO-Profile(SM) ALIF implants, which is one of the fastest growing segments in the spine market.

1 Oct 2009

Astra Tech, Dental Wings announce strategic alliance

Astra Tech, a market leader in the field of implant dentistry, announces their strategic alliance with Dental Wings, the Canadian-based provider of CAD/CAM solutions with specialized development of 3D scanners, beginning in early 2010. As a result, Dental Wings users worldwide will have the ability to remotely transfer scans to Astra Tech’s design and manufacturing centers for the production of Atlantis™ patient-specific abutments for all major implant systems.

1 Oct 2009

Asia Pacific spinal nonfusion market to increase at compound annual growth rate by 2013

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the spinal nonfusion market will increase at a compound annual growth rate of almost 17% through 2013.

1 Oct 2009

ARRA stimulus funds fuel research projects across America

The Association of American Universities (AAU), the Association of Public and Land-grant Universities (APLU), and The Science Coalition (TSC) today released highlighted examples of the important scientific work happening across the country as a result of the American Recovery and Reinvestment Act of 2009 (ARRA). The brief report summarizes just a handful of the thousands of projects benefiting from stimulus dollars.

30 Sep 2009

ETH Zurich researchers develop biodegradable bone implants of metallic glass

It is possible that broken bones will in the near future be fixed using metallic glass. Materials researchers at ETH Zurich have developed an alloy that could herald a new generation of biodegradable bone implants. Their results have been published in the online edition of Nature Materials.

29 Sep 2009

Scient’x launches its Isobar Evolution Dynamic Rod for treating lower lumbar spine pathologies

Scient’x Groupe S.A.S. (Scient’x) announces its focus on offering Dynamic Solutions for the spine. This corporate strategy positions Scient’x to be the worldwide leader in providing Dynamic Solutions for both non-fusion and fusion procedures.

29 Sep 2009

Kane Biotech's Dispersinb Topical Wound Gel passes cytotoxicity and primary skin irritation tests

Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and remove microbial biofilms is pleased to announce that DispersinB® Topical Wound Gel has passed the FDA-recommended Cytotoxicity and Primary Skin Irritation tests conducted by WuXi AppTec Inc. (St. Paul, MN) in compliance with Good Laboratory Practice (GLP). Thus, DispersinB® wound gel is considered non-cytotoxic and non-irritant.

28 Sep 2009

World’s first Cesium-131 implant for recurrent head and neck cancer performed

IsoRay, Inc. (Amex: ISR) announced today that on August 5, 2009, Dr. Bhupesh Parashar from the Department of Radiation Oncology, Dr. David Kutler of the Department of Otorhinolaryngology, and Dr. Jason Spector of the Department of Plastic Surgery at Weill Cornell Medical Center performed the world’s first Cesium-131 implant for a recurrent head and neck cancer (buccal mucosa).

28 Sep 2009

MedShape Solutions to launch the FDA-cleared Morphix Suture Anchor device

MedShape Solutions, Inc. announced today the first FDA cleared shape memory PEEK (polyaryletheretherketone) device for orthopedics using proprietary shape memory PEEK Altera(TM) material. The Morphix(TM) Suture Anchor was recently granted FDA clearance and will be released to select U.S. markets in the coming months. Over $2.5B of PEEK-based implants are sold every year in the field of orthopedics.

28 Sep 2009

Thommen Medical launches two implant conditioning systems

Thommen Medical, a leading Swiss company in the area of the oral implantology, will officially launch the latest products in the evolution of implant surface technology, APLIQUIQ and INICELL, at the 2009 AAOMS Meeting in Toronto, Canada.

28 Sep 2009

The Adiana permanent contraception system supported by UK's NICE

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the United Kingdom's National Institute for Health and Clinical Excellence (NICE), in its updated guidance for hysteroscopic sterilization, supports the use of Hologic's Adiana((R)) permanent contraception system.

25 Sep 2009

NICE updates its guidance on hysteroscopic sterilization

Conceptus, Inc., developer of the Essure procedure, the first proven non-incisional permanent birth control method available, today announced that the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom has updated its guidance on hysteroscopic sterilization to support the use of the Essure permanent birth control procedure.

24 Sep 2009

New TAXUS Liberté Stent demonstrates superior results for treating long lesions

Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX), has released comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS(R) Liberté(R) Paclitaxel-Eluting Stent System in a variety of lesions and patient groups. Three-year results from the TAXUS ATLAS Small Vessel and Long Lesion Trials continue to show significant advantages for the newer TAXUS Liberté Stent when compared to the first-generation TAXUS(R) Express(R) Stent.

23 Sep 2009

SynCardia Systems and AorTech International sign technology license agreement

On Sept. 22, SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, announced an exclusive technology licensing agreement with AorTech International plc (AIM: AOR).

23 Sep 2009

Applied Spine Technologies’ new corporate headquarters in Connecticut

Applied Spine Technologies Inc. (www.appliedspine.com), a medical device company focused on motion preservation of the lumbar spine, announced today their plans to relocate the company to Rocky Hill, Connecticut and close their New Haven office.

23 Sep 2009